TwinBeech Capital’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
TwinBeech Capital's BIIB Position: Q2 2026 in Review
TwinBeech Capital sold out of Biogen (BIIB) in Q2 2026, closing a stake of 1,100 shares — an estimated $202K sold.
TwinBeech Capital first reported a position in BIIB in Q2 2020 and held it in 12 quarters. The position peaked at $22M in Q1 2024. 1,044 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- TwinBeech Capital reported no remaining Biogen position as of Q2 2026 after selling out during the quarter.
- TwinBeech Capital sold 1,100 Biogen shares in Q2 2026, an estimated $202K.
- TwinBeech Capital first reported a position in Biogen in Q2 2020 and held it in 12 quarters.
- TwinBeech Capital's Biogen position peaked at $22M in Q1 2024.
- 1,044 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on TwinBeech Capital's 13F filing for Q2 2026, filed 14 Aug 2026.